Induction of granulation tissue for the secretion of growth factors and the promotion of bone defect repair by unknown
RESEARCH ARTICLE Open Access
Induction of granulation tissue for the
secretion of growth factors and the
promotion of bone defect repair
Xiaohua Wang†, Fuda Wei†, Fei Luo, Ke Huang and Zhao Xie*
Abstract
Background: The use of the Masquelet technique in the repair of large bone defects has gained increased acceptance
in recent years. The core of this technique is the induction of granulation tissue membrane formation and the
implantation of an autologous cancellous bone to reconstruct bone defects in the membrane. In this study, we purpose
to explore the structure of induced membrane and the content of growth factors as well to compare between the
structure and the effects on osteogenesis of induced membranes and the periosteum in animal models.
Methods: Bilateral radial bone defects were generated in 32 healthy adult rabbits. The defects were implanted
with bone cement. The induced membranes and periosteum were removed after 2, 4, 6, and 8 weeks. Thereafter,
hematoxylin-eosin staining (HE) and an enzyme-linked immunosorbent assay (ELISA) were performed to detect vascular
endothelial growth factor (VEGF), angiotensin II (ANG-II), bone morphogenetic protein 2 (BMP2), fibroblast growth factor
2 (FGF2), and prostaglandin E2 (PGE2). Proteins isolated from total cell lysates were cultured with mesenchymal stem
cells to test the cell proliferation and alkaline phosphatase activity using epimysium as a control.
Results: The induced membrane and periosteum exhibited similar structures and growth factor levels after 4 and
6 weeks. The highest concentration of BMP-2 and VEGF in the induced membranes occurred in week 6, and FGF-2
and ANG-II concentrations peaked in week 4. The thickness and vascular density of induced membranes gradually
decreased with time.
Conclusion: Induced membrane matured between the 4th and the 6th week and secreted growth factors to promote
osteogenesis. The matured induced membrane and periosteum had similar structures and abilities to promote the
osteogenesis of mesenchymal stem cells. However, the induced membrane was thicker than the periosteum.
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Introduction
Previously, large bone defects especially those with severe
soft tissue injury could only be treated by amputation. Ad-
vancements in technology have made limb salvage surgery
more common [1]. However, bone reconstruction remains
a major problem. Traditional methods for correcting bone
defects include the autologous cancellous bone graft tech-
nique [2], the vascular bone graft technique [3], and bone
transport [4]. Masquelet reported that long bone defects
could be repaired by the use of an induced membrane in
combination with an autologous cancellous bone graft, a
technique known as induced membrane [5–8]. This tech-
nique involves the implantation of polymethyl methacryl-
ate (PMMA) to induce the formation of membranes after
one-stage radical debridement and reconstruction of bone
defects using an autologous cancellous bone graft in a
span of 4 to 8 weeks. Repairs to infections, radiation, and
more complex bone defects up to 25 cm [8–11] were
achieved using this technique. Bone cement implantation
eliminated dead space to prevent infection and induced
the formation of a membrane that exhibited a biological
outcome. The membrane is primarily composed of type I
collagen and fibroblasts, and the inner surface is rich in
blood vessels [9, 12]. The membrane can secrete bone
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morphogenetic protein 2 (BMP-2), vascular endothelial
growth factor (VEGF), core binding factor α1, interleukin
6, collagenase 1, and other growth factors to stimulate
bone defect reconstruction [5, 7, 13, 14].
The morphological and molecular structural changes
of the induced membrane over time suggested that the
optimum time for grafting was from the 6th to the 8th
week [5], but some studies demonstrated that osteogenic
characteristics could persist from 4 weeks to 19 months
[15, 16]. Other studies demonstrated that induced mem-
branes might contain mesenchymal stem cells [7, 17],
with some researchers having isolated and cultured mes-
enchymal stem cells from early polyethylene-induced
membranes [18].
These findings revealed that prostaglandins (PGE2)
might prevent bone resorption via the inhibition of
osteoclast precursor differentiation [9, 13]. FGF-2 im-
proves tissue angiogenesis and promotes osteogenesis
[19, 20], while angiotensin 2 (ANG2) and VEGF both
promote angiogenesis [21–23].
Periosteum is a rich vascular tissue because it contains
numerous growth factors that promote osteogenesis and
the healing of long bone fractures [24–26]. Two distinct
levels are observed in the periosteum slice: the outer
layer (fibrous tissue layer) and the inner layer (new layer)
[27]. The epimysium surrounds the skeletal muscle with
fibrillar connective tissue that consists of fibers and nu-
merous other cell types. Isolated cells from the epimy-
sium differentiate into chondrocytes in vitro [28].
This study aimed at ascertaining whether an induced
membrane contained high concentrations of FGF-2,
ANG2, VEGF, PGE2, BMP-2, and whether the levels of
these growth factors changed over time. The structure
and function of the induced membrane was compared
to the periosteum and epimysium. The isolation of mes-
enchymal stem cells from the induced membrane was
also attempted.
Materials and methods
Rabbit bone defect-induced membrane model
construction
A total of 32 New Zealand rabbits, aged 3 to 4 months
and with an average weight of 2.75 kg, were obtained
from the Institute of Animals at the Third Military
Medical University (Chongqing, China). Laboratory
Animal Welfare and Ethics Committee Of the Third
Military Medical University approved all of the animal
protocols (SCXK-PLA-20120011). Fur was removed from
the skin, and rabbits were restrained on an operating table
and injected with 3 % sodium pentobarbital (1 ml/kg via
ear vein; Merck KgaA, Germany). A 15-mm bilateral ra-
dial bone defect was produced using a saw. The perios-
teum in the defects was carefully removed and implanted
with a 5 mm diameter, 15 mm long PMMA spacer (Smith
nephew, Switzerland). Bone cement was used to wrap the
ends of the bone defect, and the incision was sutured.
Penicillin (20,000 IU/kg) was administered intramuscu-
larly at 0, 24, and 48 h after surgery.
Specimens
Eight rabbits were euthanized at week 2, 4, 6, and 8 with
large doses of sodium pentobarbital, and 16 induced mem-
brane specimens were obtained. Periosteum was harvested
from the normal diaphyseal bone bilaterally, 2 cm away
from the bone defect, and the epimysium was harvested
from the biceps. All the operations were conducted under
sterile conditions. Four samples from each group were
stored in formalin for hematoxylin-eosin (HE) staining,
and six samples were stored in liquid nitrogen for testing
using an enzyme-linked immunosorbent assay (ELISA).
Four samples were washed with PBS buffer for protein ex-
traction and frozen at −80 °C. Two induced membrane
samples were retained for cell isolation and culturing.
HE staining
Membrane samples were stored in 10 % neutral formalin
for 24 h, and 7 μm sections were generated for HE stain-
ing. Sections were visualized using a microscopy imaging
system (Olympus, Japan) and IPP (Image Pro Plus) to
measure membrane thicknesses.
Protein extracts and ELISA
The membranes were weighed, added with protease in-
hibitors (Kangwei, Beijing, China) PBS at the ratio of 1:9
then homogenized, and the solution was centrifuged for
5 min at 12,000 rpm, 4 °C. The supernatants were used
for ELISA and cell proliferation assay. Six induced mem-
branes, periosteum, and epimysium samples were in-
cluded in every assay. Each sample was tested for the
concentration of BMP-2, VEGF, angiotensin II (ANG-II),
FGF-2, and PGE2 using an anti-rabbit monoclonal anti-
body ELISA kit (Uscnk, Wuhan, China).
Stem cell culture for proliferation
Cell viability was assessed by MTT assay. The mouse mes-
enchymal stem cell line C3H10T1/2 was donated by Pro-
fessor Dong Shiwu and seeded in 96-well culture plates
(1 × 104 cells/plate). Cells were then incubated with fresh
medium containing 20 μl of protein extracts (the method
of protein isolation from total cell lysates was described
above) for 1, 3, 6, and 9 days. MTT was added into each
well in a final concentration of 5 mg/ml for 4 h, dissolved
in dimethyl-sulfoxide (DMSO) and measured with a rapid
colorimetric assay at 570 nm of absorbed light.
Osteogenic activity detection
C3H10T1/2 cells were seeded in 96-well culture plates
(1 × 104 cells/plate) and cultured in 0.2 ml of a DMEM/
Wang et al. Journal of Orthopaedic Surgery and Research  (2015) 10:147 Page 2 of 8
F12k medium (HyClone, USA) supplemented with
10 % fetal calf serum (FCS, Gibco, USA) and 4 μl of
protein extracts that were obtained after 2, 4, 6, and
8 weeks. Medium without fetal bovine serum was used
as the control. Alkaline phosphatase (ALP) activity was
determined after 1, 3, 6, and 9 days using an ALP
ELISA kit (Jiancheng, Nanjing, China). Enzyme activity
is expressed as absorbance per microgram of protein
per minute (μg/min/μgprot).
Cell isolation and identification
The induced membranes were obtained under sterile con-
ditions. Isolated membranes were finely chopped, washed
three times in 0.01 mmol sterile PBS (pH 7.4), and sus-
pended in a DMEM/F12k medium containing 10 % fetal
bovine serum (HyClone, USA). The cultures were incu-
bated in a 5 % CO2, 37 °C environment, and the culture
medium was changed every 2 days using trypsin (HyClone,
USA) digestion. The cultures were transferred to a new
culture flask after 2 weeks. A total of 20,000 cells in the
logarithmic growth phase were suspended in 0.1 ml of
PBS-FCS and incubated with 1 μl of the FITC-conjugated
mouse anti-rabbit monoclonal antibody CD 90 (Abcam,
UK). The mouse anti-rabbit monoclonal antibodies CD 44
(ABD, UK) and CD 45 (ABD, UK) were visualized using
1 μl of a donkey anti-mouse FITC fluorescence secondary
antibody (Kangwei, Beijing, China). The cells were washed
twice with PBS for flow cytometry analysis. A total of
1 × 104 cells/plate in the logarithmic growth phase were
cultivated in osteogenic liquid which contained 1 × 10−7/l
dexamethasone, 10 mol/l β-glycerol phosphate, and
50 mg/l of vitamin C for 14 days to measure ALP activity.
A medium without induced fluid was used as a control.
Statistical Package for Social Sciences (SPSS) 19.0 soft-
ware was used for the analyses. Statistical comparisons
between two groups were performed using Student’s t
test. Multiple groups were compared using a one-way
analysis of variance (ANOVA). Data with an abnormal
distribution was analyzed using the Kruskal-Wallis H
test. A probability value of P < 0.05 was considered sig-
nificant. Charts were generated using Graphpad Prism 5.
Results
Induced membranes gradually became thinner, and
blood vessels were reduced over time
Induced membranes and periosteum contained two dis-
tinct layers: the inner layer, which is rich in blood vessels,
and the outer layer, which is comprised of fibroblasts and
collagen. However, the epimysium is just a single layer. At
any time point assessed, the induced membranes were
thicker than the periosteum and epimysium. The thick-
ness of induced membranes decreased over time. Induced
membranes were the thickest at 2 weeks (1360 ± 21 μm),
and the membranes exhibited the most abundant
vascularity with an inflammatory reaction. Vascularity was
reduced and matured at 4 (1045 ± 26 μm) and 6 weeks
(1008 ± 32 μm), and the periosteum was (890 ± 28 um) at
week 8 (Fig. 1, Table 1). We observed edema, a large num-
ber of capillaries and inflammatory cell infiltration in the
membrane, at 2 weeks.
The levels of growth factors in induced membranes were
similar to the periosteum at 4 and 6 weeks
BMP-2, VEGF, ANG-II, and FGF-2 levels were lower in
the epimysium at all time points (Fig. 2). BMP-2 (437.71 ±
19.14 pg/ml) and VEGF (362.35 ± 27.98 pg/ml) peaked in
induced membranes after 6 weeks and then began to de-
cline. The concentration of BMP-2 in induced membranes
was significantly higher than the periosteum (322.25 ±
26.32 pg/ml) at 6 weeks (P < 0.05), but it was similar at all
other time points. The VEGF concentration in induced
membranes was similar to the periosteum at week 6 but
was lower (395.15 ± 27.07 pg/ml) at the remaining points
in time (Fig. 2a, b). FGF-2 (282.23 ± 20.53 pg/ml) and
ANG-II (165.83 ± 13.67 pg/ml) peaked in the induced
membranes after 4 weeks then began to decline. FGF-2
concentrations in the periosteum were always high, and
the levels were similar to induced membranes after
4 weeks. ANG-II levels in induced membranes were higher
than in the periosteum after 2, 4, and 6 weeks (Fig. 2c, d).
However, no significant changes in ANG-II levels between
the epimysium and periosteum were observed (P > 0.05).
PGE2 levels in the induced membranes did not change
significantly over time, and there were no significant
differences between induced membranes, periosteum,
and epimysium (P > 0.05).
Induced membranes and periosteum exhibit similar
properties in promoting stem cell proliferation and
osteogenic differentiation during the maturation period
This study demonstrated that mesenchymal stem cells in a
culture medium containing total cell lysates isolated from
the epimysium proliferated at a lower level as measured by
absorbance at 570 nm. The ability of an induced mem-
brane to promote mesenchymal stem cells was similar to
the periosteum at weeks 2 and 8 (P > 0.05). The ability of
induced membranes to stimulate cell proliferation was
greater than the periosteum at weeks 4 and 6 (P < 0.05)
(Fig. 3). Mesenchymal stem cells in osteoblasts were evalu-
ated using alkaline phosphatase activity. The ALP activity
in induced membrane was lower than in the periosteum at
Table 1 The thickness of the membranes (um)
2 weeks 4 weeks 6 weeks 8 weeks
Induced membrane 1360 ± 21 1045 ± 26 1015 ± 19 1008 ± 32
Periosteum 887 ± 22 903 ± 17 899 ± 31 890 ± 28
Epimysium 912 ± 11 931 ± 20 895 ± 34 908 ± 18
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weeks 2 and 8 (P < 0.05). The ALP activity in induced
membranes at weeks 4 and 6 was similar to the periosteum
(Fig. 4). However, the stem cell proliferation generated by
induced membranes was the strongest, and the ALP activ-
ity in the induced membranes was the highest after 4 weeks
compared to other time points (Fig. 5).
Isolated CD44+ cells exhibit osteogenesis
Induced membrane specimens were isolated after 2, 4, 6,
and 8 weeks, and cultured adherent cells were fusiform or
polygonal which contains one nucleus. Cells proliferated
quickly and did not require stringent conditions. Flow cy-
tometry detected positive rates of CD44 at 98.5 %, CD90
Fig. 2 ELISA of growth factors in induced membranes, periosteum, and epimysium. a BMP-2 in induced membranes peaked at 4 weeks, higher
than the periosteum and epimysium (P < 0.05). b VEGF in induced membranes peaked at 6 weeks and almost equaled the periosteum (P > 0.05).
c FGF-2 in induced membranes peaked at 4 weeks (P > 0.05). d ANG-II in induced membranes peaked at 4 weeks (P < 0.05)
Fig. 1 Induced membrane, periosteum, and epimysium sections with hematoxylin-eosin staining (×100). a A large number of capillaries and
inflammatory cell infiltration at 2 weeks membrane. b Small blood vessels formed and vessel number decreased at 6 weeks. c The periosteum,
inner layer of a large number of vessels and the outer layer of fibrous tissue. d The epimysium, no obvious hierarchy; contains blood vessels
with fat vacuoles. Black arrows indicate blood vessels (Bar = 200 μm)
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at 15 %, and CD45 at 1.35 %. ALP activity was significantly
higher in induced membranes than the control group after
2 weeks in culture (P < 0.05).
Discussion
The treatment of large bone defects remains challenging
for surgeons. Induced membrane technology is an in-
novative method that improves the reconstruction of
segmental bone defects. This technique is successful in
the repair of large bone defects [5, 10, 29–31]. Bone ce-
ment implantation eliminates dead space and prevents
fibrous tissue invasion at the recipient site. Implantation
also induces the formation of the surrounding mem-
brane, which is part of the histological characteristics
and molecular components that were studied previously
[7]. The present study compared the structure and
Fig. 3 Proteins cultured with mouse mesenchymal stem cells to examine cell proliferation. a, d At weeks 2 and 8, the OD values for the induced
membrane samples were almost equal to the periosteum (P > 0.05). b, c The OD values of the induced membrane samples were higher than the
periosteum (P < 0.05)
Fig. 4 Alkaline phosphatase activity. a, d At weeks 2 and 8, the ALP activity in the periosteum group was higher than in the induced membrane
group (P < 0.05). b, c Induced membrane and periosteum groups were almost equal (P > 0.05) and both were higher than the epimysium (P < 0.05)
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effects of induced membranes, periosteum, and epimy-
sium on osteogenesis and observed the structural and
functional changes of the membrane over time.
HE staining revealed that mature induced membrane
and periosteum contained two layers: an inner layer rich
in blood vessels and an outer layer of fibrous compo-
nents. These findings are consistent with previous stud-
ies [32], but the induced membranes in our study were
much thicker at all time points. Early studies suggested
that induced membranes are a fibrous tissue with a rich
blood supply and a structure that is maintained for a
long time [16, 33]. However, our study demonstrated se-
vere inflammation and many tiny blood vessels after
2 weeks, then the membrane thickness and vascularity
gradually decreased over time to form a periosteum-like
tissue. Therefore, we conclude that the induced mem-
branes are a parallel to periosteal tissues that degenerate
over time.
BMP-2 is an initial signaling molecule in osteogenic dif-
ferentiation in mesenchymal stem cells. BMP-2 enriches
bone progenitor cells and promotes progenitor cell osteo-
genic differentiation [34]. VEGF promotes angiogenesis at
injury sites and participates in the mobilization of mesen-
chymal stem cells in bone marrow. BMP-2 and VEGF
boost the osteogenic differentiation of mesenchymal stem
cells [35, 36]. We detected high concentrations of BMP-2
and VEGF in induced membranes and periosteum. Previ-
ous studies reported peak concentrations of BMP-2 and
VEGF in induced membranes after 4 weeks [7, 14], but our
peak concentrations occurred during the 6th week. We
also detected two new growth factors, FGF-2 and ANG-II,
which promote angiogenesis or osteogenesis [19, 20, 23].
FGF-2 and ANG-II reached peak concentrations in the 4th
week in rabbits, but it might be different for humans.
Therefore, we considered weeks 4 to 6 as the best grafting
period, which conforms to the stem cell proliferation and
osteogenic differentiation results. Previous studies reported
a high concentration of prostaglandins in the prosthesis of
joint replacement, which might play an important role in
the prevention of absorbed bones [9, 13]. However, our re-
sults demonstrated that PGE2 content was not very high,
and its effect in induced membranes might be exaggerated.
Our study demonstrated that protein extracts from in-
duced membranes included growth factors that pro-
moted the proliferation and differentiation of stem cells
[7]. Our study also indicated that the ability of induced
membranes to promote osteogenic differentiation of stem
cells was similar to the periosteum at 4 to 6 weeks, but
the content of BMP-2 in induced membranes was signifi-
cantly higher at 6 weeks than the periosteum. These re-
sults indicate that there may be other significant factors
involved in the promotion of bone formation. The ability
of induced membranes to promote stem cell proliferation
was stronger at the 4th to 6th week, which implies that
the most appropriate time for two-stage grafting is weeks
4 to 6 according to our rabbit models. However, infection
must also be controlled during the reconstruction of
osteomyelitis and infected bone defects. Therefore, graft-
ing time might be delayed for these patients.
Many studies have demonstrated that induced mem-
branes might contain mesenchymal stem cells [14, 18, 37].
Henrich D et al. [38] found that the membranes induced
at the femur defect (at 2 weeks) and in periosteum contain
mesenchymal stem cells. These multi-potent cells differ-
entiate into osteogenic and chondrogenic cells in animals
and humans [32, 39]. Mesenchymal stem cells have not
previously been isolated from induced membranes. Our
study successfully isolated adherent cells from induced
Fig. 5 Comparison of induced membranes in the promotion of stem cell proliferation and osteogenic differentiation. a ALP activity was highest at
week 4, lowest at weeks 2 and 8, and moderate at week 6 (P< 0.05). b OD values at weeks 4 and 6 were higher than at weeks 2 and 8 (P< 0.05)
Wang et al. Journal of Orthopaedic Surgery and Research  (2015) 10:147 Page 6 of 8
membranes for the first time, but we failed to demonstrate
that these cells were mesenchymal stem cells. However,
flow cytometry detected a positivity rate for the cell sur-
face marker CD44 of 98.5 %, and these cells differentiated
into osteogenic cells under an inducing agent. Therefore,
we concluded that induced membranes likely promoted
the repair and reconstruction of bone defects at defect
sites, but this hypothesis requires further analysis.
The study was limited because it was performed on
small animals, and the results might be different in hu-
man trials. Furthermore, this study primarily examined
the structure of three types of membranes, but there was
no exploration of the mechanisms of growth factor ac-
tion. This study also failed to identify the cells that were
isolated from the induced membranes.
Conclusions
Induced membranes matured at the 4th to 6th week and
secretion of growth factors to promote osteogenesis; the
matured induced membrane and periosteum have simi-
lar structures and abilities to promote the osteogenesis
of mesenchymal stem cells. We therefore concluded that
the best time for grafting was at week 4 to 6.
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